Literature DB >> 8037761

Cloning and analysis of MAGE-1-related genes.

M Ding1, R J Beck, C J Keller, R G Fenton.   

Abstract

The spectrum of MAGE gene expression in the human melanoma cell line DM150 was examined using reverse transcription polymerase chain reaction and cDNA cloning. We have isolated five full-length cDNAs from DM150 which were identified as MAGE-1, MAGE-3, MAGE-12 and two previously undescribed MAGE genes, MAGE-3b and MAGE-X2. DNA sequence analysis of the coding regions of the MAGE-3b and MAGE-X2 genes revealed 83% and 88% identity with MAGE-1, while MAGE-3b was 98% homologous with the full length MAGE-3 clone. The predicted amino acid sequences of MAGE-X2 and MAGE-3b contain consensus HLA-A1 peptide binding motifs, suggesting that, like MAGE-1, they may code for tumor-associated antigens. In addition, a nonamer peptide encoded by both the MAGE-3 and MAGE-12 genes was shown by direct binding studies to contain an aggretope for HLA-A2.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8037761     DOI: 10.1006/bbrc.1994.1963

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  Beyond cancer vaccines: a reason for future optimism with immunomodulatory therapy.

Authors:  Michael Postow; Margaret K Callahan; Jedd D Wolchok
Journal:  Cancer J       Date:  2011 Sep-Oct       Impact factor: 3.360

2.  Isolation and characterization of a MAGE gene family in the Xp21.3 region.

Authors:  F Muscatelli; A P Walker; E De Plaen; A N Stafford; A P Monaco
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

Review 3.  Biological functions of melanoma-associated antigens.

Authors:  Jiang Xiao; Hong-Song Chen
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

Review 4.  Immunotherapy of cancer in 2012.

Authors:  John M Kirkwood; Lisa H Butterfield; Ahmad A Tarhini; Hassane Zarour; Pawel Kalinski; Soldano Ferrone
Journal:  CA Cancer J Clin       Date:  2012-05-10       Impact factor: 508.702

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.